Concepedia

Hamid Tayebi Khosroshahi

HT

19

Publications

633

Citations

14

H-Index

2005

Active since

Affiliations

Tabriz University of Medical Sciences(Current)

Biotechnology Research Center

Imam Reza Hospital

University of California, Irvine

Hamid Tayebi Khosroshahi is an author at Tabriz University of Medical Sciences specializing in medicine, intestinal microbiota, and microbiome.

ORCID

Top concepts

Publications per year

2005–2023

19

Publications

19

Amylose resistant starch (HAM‐RS2) supplementation increases the proportion of <i>Faecalibacterium</i> bacteria in end‐stage renal disease patients: Microbial analysis from a randomized placebo‐controlled trial

Michael Laffin, Hamid Tayebi Khosroshahi, Heekuk Park et al. · Hemodialysis International · 2019 · 88 citations

Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial

Hamid Tayebi Khosroshahi, Nosratola D. Vaziri, Behzad Abedi et al. · Hemodialysis International · 2018 · 79 citations · Full text

Risk Factors for COVID-19.

Jalil Rashedi, Behroz Mahdavi Poor, Vahid Asgharzadeh et al. · PubMed · 2020 · 77 citations

, , +19

Effects of fermentable high fiber diet supplementation on gut derived and conventional nitrogenous product in patients on maintenance hemodialysis: a randomized controlled trial

Hamid Tayebi Khosroshahi, Behzad Abedi, Morteza Ghojazadeh et al. · Nutrition & Metabolism · 2019 · 65 citations · Full text

The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease; a randomized clinical trial

Hamid Tayebi Khosroshahi, Afshin Habibzadeh, Bahram Niknafs et al. · Journal of Renal Injury Prevention · 2016 · 52 citations · Full text

Rows per page

1–5 of 19